BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37291363)

  • 21. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
    O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
    Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
    Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinic Factors Associated With Mailed Fecal Immunochemical Test (FIT) Completion: The Difference-Making Role of Support Staff.
    Davis MM; Schneider JL; Petrik AF; Miech EJ; Younger B; Escaron AL; Rivelli JS; Thompson JH; Nyongesa D; Coronado GD
    Ann Fam Med; 2022; 20(2):123-129. PubMed ID: 35346927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized controlled trial to improve colon cancer screening in rural family medicine: an Iowa Research Network (IRENE) study.
    Levy BT; Xu Y; Daly JM; Ely JW
    J Am Board Fam Med; 2013; 26(5):486-97. PubMed ID: 24004700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Text Messaging and Opt-out Mailed Outreach in Colorectal Cancer Screening: a Randomized Clinical Trial.
    Huf SW; Asch DA; Volpp KG; Reitz C; Mehta SJ
    J Gen Intern Med; 2021 Jul; 36(7):1958-1964. PubMed ID: 33511567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial.
    Kapinos KA; Halm EA; Murphy CC; Santini NO; Loewen AC; Skinner CS; Singal AG
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2383-2392.e4. PubMed ID: 35144024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis.
    Jager M; Demb J; Asghar A; Selby K; Mello EM; Heskett KM; Lieberman AJ; Geng Z; Bharti B; Singh S; Gupta S
    Dig Dis Sci; 2019 Sep; 64(9):2489-2496. PubMed ID: 30915656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review.
    Issaka RB; Avila P; Whitaker E; Bent S; Somsouk M
    Prev Med; 2019 Jan; 118():113-121. PubMed ID: 30367972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Financial Incentives on Patient Use of Mailed Colorectal Cancer Screening Tests: A Randomized Clinical Trial.
    Mehta SJ; Pepe RS; Gabler NB; Kanneganti M; Reitz C; Saia C; Teel J; Asch DA; Volpp KG; Doubeni CA
    JAMA Netw Open; 2019 Mar; 2(3):e191156. PubMed ID: 30901053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
    O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
    Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mailed FIT (fecal immunochemical test), navigation or patient reminders? Using microsimulation to inform selection of interventions to increase colorectal cancer screening in Medicaid enrollees.
    Davis MM; Nambiar S; Mayorga ME; Sullivan E; Hicklin K; O'Leary MC; Dillon K; Hassmiller Lich K; Gu Y; Lind BK; Wheeler SB
    Prev Med; 2019 Dec; 129S():105836. PubMed ID: 31635848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.
    Davis SN; Christy SM; Chavarria EA; Abdulla R; Sutton SK; Schmidt AR; Vadaparampil ST; Quinn GP; Simmons VN; Ufondu CB; Ravindra C; Schultz I; Roetzheim RG; Shibata D; Meade CD; Gwede CK
    Cancer; 2017 Apr; 123(8):1390-1400. PubMed ID: 27906448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal Cancer Screening and Yield in a Mailed Outreach Program in a Safety-Net Healthcare System.
    Murphy CC; Halm EA; Zaki T; Johnson C; Yekkaluri S; Quirk L; Singal AG
    Dig Dis Sci; 2022 Sep; 67(9):4403-4409. PubMed ID: 34800219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening.
    Schlichting JA; Mengeling MA; Makki NM; Malhotra A; Halfdanarson TR; Klutts JS; Levy BT; Kaboli PJ; Charlton ME
    J Am Board Fam Med; 2015; 28(4):494-7. PubMed ID: 26152441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Patient Portal-Based Commitment Device to Improve Adherence with Screening for Colorectal Cancer: a Retrospective Observational Study.
    Hahn EE; Baecker A; Shen E; Haupt EC; Wakach W; Ahuja A; Imley TM; Gould MK; Kanter M
    J Gen Intern Med; 2021 Apr; 36(4):952-960. PubMed ID: 33474640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program.
    Green BB; Baldwin LM; West II; Schwartz M; Coronado GD
    J Prim Care Community Health; 2020; 11():2150132720958525. PubMed ID: 32912056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.